Medicines for treating stomach cancer are FDA approved

The list of common stomach cancer medications and combinations of drugs used in stomach cancer is approved by the U.S. Food and Drug Administration (FDA).

Medication for treating stomach cancer is approved

Cyramza (Ramucirumab)

Ramucirumab is approved for use alone or with other drugs to treat:

  • Metastatic colorectal cancer: It is used with Folfiri in patients with more severe illness during or after treatment with certain types of anticancer drugs.
  • Metastatic non-small cell lung cancer: It is used with docetaxel in patients with more severe illness after treatment with certain chemotherapy. For patients with cancer that has a mutation in the epidermal growth factor receptor (EGFR) gene or anaplastic lymphoma kinase (ALK) gene, ramucirumab is used if their disease has gotten worse after treatment. with FDA -approved treatment for mutations.
  • Adenocarcinoma of stomach or gastric junction adenocarcinoma (a rare type of cancer of the esophagus) advanced or metastatic: It is used in patients with more severe disease after treatment with certain chemotherapy. It is used alone or with paclitaxel.

Ramucirumab is also being studied in the treatment of other cancers.

Cyramza 10 mg ml of Ramucirumab is an effective cancer inhibitor (1)
Cyramza 10 mg ml of Ramucirumab is an effective cancer inhibitor (1)

Herceptin (Trastuzumab)

Trastuzumab is approved for use alone or with other drugs to treat:

Cancer a HER2-positive breast in patients with:

Negative receptor hormone or high-risk cancer is given:

  • As a combination therapy with: Doxorubicin hydrochloride, cyclophosphamide and paclitaxel, docetaxel; or Docetaxel and carboplatin.
  • Alone after combination therapy including anthracycline chemotherapy.

Metastatic cancer is given:

  • With paclitaxel is the first treatment for metastatic disease;
  • Alone in patients who have received at least one chemotherapy treatment for metastatic disease.

This use is approved for trastuzumab brands of Herceptin, Ogivri and Herzuma.

Adenocarcinoma of stomach or gastric junction adenocarcinoma has spread: It is used in patients with HER2 +. This use is approved for the trastuzumab brands of Herceptin and Ogivri.

Trastuzumab is also available in other forms, in combination with hyaluronidase. Trastuzumab is also being studied in the treatment of other types of cancer.

Herceptin Medicine 150mg Trastuzumab Cancer (1)
Herceptin Medicine 150mg Trastuzumab Cancer (1)

Keytruda (Pembrolizumab)

Pembrolizumab is a cancer medicine used to treat:

  • Malignant tumors, skin cancer
  • Non-small cell lung cancer (NSCLC)
  • Hodgkin’s classic lymphoma
  • Urinary cancer, bladder cancer and urinary tract
  • Cancer affecting the head and neck squamous cell carcinoma (HNSCC)
  • Stomach cancer in cancer patients has PD-L1 protein

Pembrolizumab is mainly used for advanced cancers, has spread to other parts of the body, or has not responded to other treatments.

Pembrolizumab is also used as an adjunct to help prevent cancer coming back after they have surgery to remove the malignant tumor.

Pembrolizumab is used exclusively except NSCLC without psoriasis, in which it is used in combination with pemetrexed and platinum chemotherapy.

Keytruda 100mg 4ml Pembrolizumab Anticholinergic Treatment (4)
Keytruda 100mg 4ml Pembrolizumab Anticholinergic Treatment (4)

Taxotere (Docetaxel)

Docetaxel is approved for use alone or with other drugs to treat:

  • Breast cancer has progressed or has spread and has not gotten better with other chemotherapy. It is also used to treat button-positive breast cancer and can be removed by surgery.
  • Non-small cell lung cancer in some patients with locally advanced or metastatic cancer.
  • Prostate cancer has spread in men with cancer that is refractory material, unresponsive to hormone therapy.
  • Squamous cell carcinoma of the head and neck is locally progressive and cannot be treated with surgery.
  • Metastatic adenocarcinoma of gastric gland or gastric gland : It is used in patients who have not been treated with chemotherapy.

Docetaxel is also being studied in the treatment of other types of cancer.

Xeloda (Capecitabine)

Capecitabine is approved to treat:

  • Adjuvant treatment of patients after stage III colon cancer surgery .
  • Colorectal cancer has spread to other parts of the body.
  • The first treatment of advanced gastric cancer is combined with platinum therapy.
  • Combined with docetaxel to treat patients with metastatic breast cancer or local progression after failure in cytotoxic chemotherapy. Previous therapy should include an anthracycline.

Considered as monotherapy to treat patients with metastatic breast disease or local progression after failure of taxan and chemotherapy regimen containing anthracycline or not prescribed anthracycline therapy.

Capecitabine is also being studied in the treatment of other types of cancer.

Xeloda medicine 500mg Capecitabine anti-aging medication (1)
Xeloda medicine 500mg Capecitabine anti-aging medication (1)

Efudex (5-FU)

Fluorouracil injection is approved for treatment:

  • Breast cancer
  • Colorectal cancer.
  • Stomach cancer.
  • Pancreatic Cancer.

Fluorouracil is also known as 5-FU. Fluorouracil is also being studied in treating other conditions and types of cancer.

Fluorouracil is also available in topical form.

Doxorubicin hydrochloride

Doxorubicin hydrochloride is approved for use alone or with other drugs to treat:

  • Acute lymphoblastic leukemia.
  • Acute myeloid leukemia (AML).
  • Breast cancer: It is also used as an adjunct to breast cancer that has spread to the lymph nodes after surgery.
  • Stomach cancer.
  • Hodgkin’s lymphoma.
  • Neuroblastoma.
  • Non-Hodgkin’s lymphoma.
  • Ovarian Cancer.
  • Small cell lung cancer.
  • Soft tissue and bone sarcomas.
  • Thyroid Cancer.
  • Transitional cell bladder cancer.
  • Wilms tumor.

Doxorubicin hydrochloride is also being studied in the treatment of other types of cancer.

Doxorubicin hydrochloride is also available in another form called doxorubicin hydrochloride liposomes.

Mitomycin C

Mitomycin C is approved for use alone or with other drugs to treat:

  • Adenocarcinoma or advanced metastatic stomach and pancreatic cancer: It is used in patients who do not better treat other types of treatment.
  • Used in combination with other cancer medicines to treat stomach and pancreatic cancer.

Mitomycin C is also being studied in the treatment of other types of cancer.

The drug is used in combination in gastric cancer

Chemotherapy is usually given in the form of a combination of drugs. The combination usually works better than the individual drugs because different drugs destroy cell cancer in different ways.

Fluorouracil – Leucovorin Calcium (FU-LV )

FU-LV is used to treat:

  • Colorectal cancer
  • Stomach cancer.
  • Stomach cancer.

This combination can also be used with other drugs or treatments or to treat other types of cancer.

Docetaxel – Cisplatin – Fluorouracil (TPF)

TPF is used to treat:

  • Stomach cancer has progressed.
  • Squamous cell carcinoma of the head and neck is locally advanced.

This combination can also be used with other drugs or treatments or to treat other types of cancer.

Capecitabine – rinotecan Hydrochloride (XELIRI)

XELIRI is used for combination:

  • Colorectal cancer has spread.
  • Esophageal cancer has progressed or has spread.
  • Stomach cancer has progressed or has spread.

This combination can also be used with other drugs or treatments or to treat other types of cancer.

Medication for treating stomach cancer (2)
Medication for treating stomach cancer (2)

Source Reference drugs to treat stomach cancer:

Last Updated on

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.